Schmitt, F.; Gosch, L.C.; Dittmer, A.; Rothemund, M.; Mueller, T.; Schobert, R.; Biersack, B.; Volkamer, A.; Höpfner, M.
Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function. Int. J. Mol. Sci. 2019, 20, 383.
https://doi.org/10.3390/ijms20020383
AMA Style
Schmitt F, Gosch LC, Dittmer A, Rothemund M, Mueller T, Schobert R, Biersack B, Volkamer A, Höpfner M.
Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function. International Journal of Molecular Sciences. 2019; 20(2):383.
https://doi.org/10.3390/ijms20020383
Chicago/Turabian Style
Schmitt, Florian, Lisa Chiara Gosch, Alexandra Dittmer, Matthias Rothemund, Thomas Mueller, Rainer Schobert, Bernhard Biersack, Andrea Volkamer, and Michael Höpfner.
2019. "Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function" International Journal of Molecular Sciences 20, no. 2: 383.
https://doi.org/10.3390/ijms20020383
APA Style
Schmitt, F., Gosch, L. C., Dittmer, A., Rothemund, M., Mueller, T., Schobert, R., Biersack, B., Volkamer, A., & Höpfner, M.
(2019). Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function. International Journal of Molecular Sciences, 20(2), 383.
https://doi.org/10.3390/ijms20020383